Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Agoniste And NotJ. Ong

List of bibliographic references

Number of relevant bibliographic references: 17.
Ident.Authors (with country if any)Title
000821 David J. Kuter [États-Unis] ; James B. Bussel [États-Unis] ; Adrian Newland [Royaume-Uni] ; Ross I. Baker [Australie] ; Roger M. Lyons [États-Unis] ; Jeffrey Wasser [États-Unis] ; Jean-Francois Viallard [France] ; Gail Macik [États-Unis] ; Mathias Rummel [Allemagne] ; KUN NIE [États-Unis] ; Susie Jun [États-Unis]Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy
001B59 Andrei Cividjian [France] ; Emil Toader [France] ; Karel H. Wesseling [Pays-Bas] ; John M. Karemaker [Pays-Bas] ; Robin Mcallen [Australie] ; Luc Quintin [France]Effect of clonidine on cardiac baroreflex delay in humans and rats
001F94 A. Hanna-Elias [Australie] ; D. T. Manallack [Australie] ; I. Berque-Bestel [France] ; H. R. Irving [Australie] ; I. M. Coupar [Australie] ; M. N. Iskander [Australie]Synthesis and Preliminary Screening of Novel Tryptamines as 5-HT4 Receptor Ligands
002301 Christian W. Gruber [Autriche] ; Markus Muttenthaler [Australie] ; Michael Freissmuth [Autriche]Ligand-Based Peptide Design and Combinatorial Peptide Libraries to Target G Protein-Coupled Receptors
002790 Craig S. Mclachlan [Singapour, Australie] ; Justin M. Farook [Singapour] ; Valérie Dauge [France] ; Peter T. Wong [Singapour]The CCK2 agonist BC-264 decreases predatory fear freezing at high but not low dosages in PVG hooded rats during initial exposure to a cat
002813 Amir Hanna-Elias [Australie] ; David T. Manallack [Australie] ; Isabelle Berque-Bestel [France] ; Helen R. Irving [Australie] ; Ian M. Coupar [Australie] ; Magdy N. Iskander [Australie]Synthesis and preliminary screening of novel indole-3-methanamines as 5-HT4 receptor ligands
002A27 M. Marre [France] ; J. Shaw [Australie] ; M. Br Ndle [Suisse] ; W. M. W. Bebakar [Malaisie] ; N. A. Kamaruddin [Malaisie] ; J. Strand [Finlande] ; M. Zdravkovic [Danemark] ; T. D. Le Thi [Danemark] ; S. Colagiuri [Australie]Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)
003629 Seung-Kwon Yang [Australie] ; Helena C. Parkington [Australie] ; Jacques Epelbaum [France] ; Damien J. Keating [Australie] ; CHEN CHEN [Australie]Somatostatin decreases voltage-gated Ca2+ currents in GH3 cells through activation of somatostatin receptor 2
004E68 Jean-Marie Boeynaems [Belgique] ; Francoise Wilkin [Belgique] ; Frédéric Marteau [Belgique] ; Xavier Duhant [Belgique] ; Pierre Savi [France] ; Nathalie Suarez Gonzalez [Belgique] ; Bernard Robaye [Belgique] ; Didier Communi [Belgique]P2Y receptors: New subtypes, new functions
005367 Ricardo V. Reges [France] ; Leni G. H. Bonagamba [France] ; Anne Nosjean [France] ; Raul Laguzzi [France] ; Benedito H. Machado [France]Involvement of NMDA receptors in the pressor response to microinjection of 5-HT3 agonist into the NTS of awake rats
005930 Benno U. Ihle [Australie] ; Carole Ichai [France] ; Jérome Soubielle [France] ; Michel Caries [France] ; Carine Giunti [France] ; Dominique Grimaud [France]Comparison of the renal effects of low to high doses of dopamine and dobutamine in critically ill patients. Authors' reply
005A30 N. Vibert [Australie] ; M. Beraneck [France] ; A. Bantikyan [Arménie] ; P.-P. Vidal [France]Vestibular compensation modifies the sensitivity of vestibular neurones to inhibitory amino acids
005A79 E. H. Walters [Australie] ; L. Bjermer [Norvège] ; P. Faurschou [Danemark] ; T. Sandström [Suède]The anti-inflammatory profile of inhaled corticosteroids combined with salmeterol in asthmatic patients
005C82 N. J. Talley [Australie] ; M. Verlinden [États-Unis] ; W. Snape [États-Unis] ; J. A. Beker [Pays-Bas] ; P. Ducrotte [France] ; A. Dettmer ; H. Brinkhoff ; E. Eaker [États-Unis] ; G. Ohning [États-Unis] ; P. B. Miner [États-Unis] ; J. R. Mathias [États-Unis] ; I. Fumagalli [Suisse] ; D. Staessen [Belgique] ; R. J. Mack [États-Unis]Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying : a randomized double-blind placebo-controlled trial
006294 F. J. Mercier [France] ; D. Benhamou [France]Promising non-narcotic analgesic techniques for labour
006A97 J. R. Redman [Australie] ; B. Guardiola-Lemaitre [France] ; M. Brown [Australie] ; P. Delagrange [France] ; S. M. Armstrong [Australie]Dose dependent effects of S-20098, a melatonin agonist, on direction of re-entrainment of rat circadian activity rhythms
006B90 G. Lacey [Australie] ; P. Berthelot [France] ; C. Vaccher [France] ; N. Flouquet [France] ; M. P. Vaccher [France] ; M. Debaert [France] ; D. R. Curtis [Australie]Thienyl-GABA derivatives as specific baclofen agonists in the rat and cat spinal cord in vivo

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024